Weng LC, Hall AW, Choi SH, et al. Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation. Circ Genom Precis Med. 2020;13(5):387-395. doi:10.1161/CIRCGEN.119.002874
Ahlberg G, Refsgaard L, Lundegaard PR, et al. Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation. Nat Commun. 2018;9(1):4316. doi:10.1038/s41467-018-06618-y
Choi SH, Weng LC, Roselli C, et al. Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. 2018;320(22):2354-2364. doi:10.1001/jama.2018.18179
Newton-Cheh C. Should Identifying a Titin Truncating Variant Change the Management of Patients With Dilated Cardiomyopathy?. J Am Coll Cardiol. 2017;70(18):2275-2277. doi:10.1016/j.jacc.2017.09.020
Perić S, Glumac JN, Topf A, et al. A novel recessive TTN founder variant is a common cause of distal myopathy in the Serbian population. Eur J Hum Genet. 2017;25(5):572-581. doi:10.1038/ejhg.2017.16
Oates EC, Jones KJ, Donkervoort S, et al. Congenital Titinopathy: Comprehensive characterization and pathogenic insights. Ann Neurol. 2018;83(6):1105-1124. doi:10.1002/ana.25241
Roberts AM, Ware JS, Herman DS, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 2015;7(270):270ra6. doi:10.1126/scitranslmed.3010134